INSMED INC's ticker is and the CUSIP is 457669AA7. A total of 47 filers reported holding INSMED INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $347,000 | +18.8% | 330,000 | +26.9% | 0.03% | -8.8% |
| Q1 2021 | $292,000 | -94.1% | 260,000 | -94.1% | 0.03% | -94.4% |
| Q4 2020 | $4,951,000 | -38.9% | 4,377,000 | -40.9% | 0.61% | -42.3% |
| Q3 2020 | $8,103,000 | -22.2% | 7,410,000 | -30.5% | 1.05% | -27.2% |
| Q2 2020 | $10,413,000 | +12.9% | 10,660,000 | -2.3% | 1.45% | +30.8% |
| Q1 2020 | $9,226,000 | -56.0% | 10,910,000 | -49.6% | 1.11% | -36.4% |
| Q4 2019 | $20,950,000 | +13.9% | 21,640,000 | -1.7% | 1.74% | +18.9% |
| Q3 2019 | $18,401,000 | +3.8% | 22,020,000 | +21.1% | 1.46% | -6.4% |
| Q2 2019 | $17,730,000 | +27.9% | 18,185,000 | +32.4% | 1.56% | +19.5% |
| Q1 2019 | $13,865,000 | +16.3% | 13,738,000 | -17.2% | 1.31% | +1.6% |
| Q4 2018 | $11,917,000 | -7.0% | 16,601,000 | +9.9% | 1.29% | +16.1% |
| Q3 2018 | $12,810,000 | -1.6% | 15,101,000 | +6.5% | 1.11% | +7.0% |
| Q2 2018 | $13,020,000 | +30.3% | 14,186,000 | +26.3% | 1.04% | +61.3% |
| Q1 2018 | $9,993,000 | – | 11,236,000 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 2,974,000 | $2,536,000 | 1.90% |
| Mohican Financial Management, LLC | 500,000 | $422,000 | 1.47% |
| LINDEN ADVISORS LP | 51,146,000 | $43,311,000 | 1.32% |
| ZAZOVE ASSOCIATES LLC | 15,101,000 | $12,810,000 | 1.11% |
| DLD Asset Management, LP | 24,500,000 | $20,911,000 | 1.03% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 31,749,000 | $26,863,000 | 0.55% |
| Cheyne Capital Management (UK) LLP | 1,000,000 | $853,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 6,000,000 | $5,050,000 | 0.39% |
| Jabre Capital Partners S.A. | 1,100,000 | $943,000 | 0.31% |
| Orbimed Advisors | 26,500,000 | $22,611,000 | 0.27% |